Autori: Seferovic Petar M
Naslov | Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry (Article) |
Autori | Shahim Bahira ... Seferovic Petar M ![]() |
Info | EUROPEAN JOURNAL OF HEART FAILURE, (2023), vol. 25 br. 7, str. 1049-1060 |
Projekat | Region Stockholm clinical post-doctoral appointment [FoUI-FoUI-969 615]; Swedish Heart-Lung Foundation [20 220 524, 20 190 322, 523-2014-2336, J3-3076]; Swedish Research Council [20150557, 202201472, 20180899]; Slovenian Research Agency [20190310]; Karolinska Institutet; Stockholm County Council [20170112, 20190525] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology (Article) |
Autori | Metra Marco ... Ristic Arsen D ![]() ![]() |
Info | EUROPEAN JOURNAL OF HEART FAILURE, (2023), vol. 25 br. 6, str. 776-791 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry (Article) |
Autori | Chioncel Ovidiu ... Seferovic Petar M ![]() |
Info | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, (2023), vol. 30 br. 13, str. 1346-1358 |
Projekat | Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Daiichi Sankyo Europe GmbH; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; Servier; Vifor |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Strength in synergy: Cardiometabolic effects of sacubitril/ valsartan in heart failure and diabetes (vol 15, pg 293, 2023) (Correction) |
Autori | Seferovic Petar M ![]() ![]() |
Info | INTERNATIONAL JOURNAL OF CARDIOLOGY, (2023), vol. 376 br. , str. 176-176 |
Projekat | Italian Ministry of Health (Ricerca Corrente) [20/1819] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC-HFA EORP Heart Failure Long-Term Registry (Article) |
Autori | Kaplon-Cieslicka Agnieszka ... Seferovic Petar M ![]() |
Info | EUROPEAN JOURNAL OF HEART FAILURE, (2023), vol. 25 br. 9, str. 1571-1583 |
Projekat | Oversight Committee; Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Daiichi Sankyo Europe GmbH; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; Servier; Vifor |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society (Review) |
Autori | Tsutsui Hiroyuki ... Seferovic Petar M ![]() |
Info | EUROPEAN JOURNAL OF HEART FAILURE, (2023), vol. 25 br. 5, str. 616-631 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology (Article) |
Autori | Gustafsson Finn ... Seferovic Petar M ![]() |
Info | EUROPEAN JOURNAL OF HEART FAILURE, (2023), vol. 25 br. 4, str. 457-468 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry (Editorial Material) |
Autori | Kapelios Chris J ... Seferovic Petar M ![]() |
Info | EUROPEAN HEART JOURNAL, (2023), vol. 44 br. 17, str. 1526-1529 |
Projekat | Abbott Vascular Int.; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; BostonScientific; Bristol-Myers Squibb; Pfizer Alliance; Daiichi-Sankyo Europe; Alliance Daiichi-SankyoEurope GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Fondazione Internazionale Menarini; MSD; Novartis Pharma AG; ResMed; Sanofi; Servier; Vifor; Karolinska Institutet; Swedish Research Council [523-2014-2336]; Swedish Heart Lung Foundation [20150557, 20190310]; Stockholm County Council [20170112, 20190525] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes (Editorial Material) |
Autori | Seferovic Petar M ![]() ![]() |
Info | INTERNATIONAL JOURNAL OF CARDIOLOGY, (2023), vol. 371 br. , str. 293-294 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Global burden of heart failure: a comprehensive and updated review of epidemiology (Review) |
Autori | Savarese Gianluigi Becher Peter Moritz Lund Lars H Seferovic Petar M ![]() |
Info | CARDIOVASCULAR RESEARCH, (2022), vol. 118 br. 17, str. 3272-3287 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|